Study Of Capecitabine Combined With Camrelizumab For Non-pCR TNBC With TLS After Neoadjuvant Chemoterapy

NCT06313463 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

375

Enrollment

OTHER

Sponsor class

Conditions

Breast Neoplasms

Interventions

DRUG: Carrellizumab + Capecitabine
DRUG: Placebo + Capecitabine

Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University